Novartis Pharmaceuticals Corporation, one of the Novartis Group Companies, researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including central nervous system disorders, organ transplantation, cardiovascular diseases, dermatological diseases, cancer and arthritis. The company’s mission is to improve people’s lives by pioneering novel healthcare solutions.
Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of the Novartis Group (NYSE:NVS), a world leader in healthcare with core businesses in pharmaceuticals, consumer health, generics, eye-care, and animal health. In 2000, the Group’s ongoing businesses achieved sales of CHF 29.1 billion (USD 17.2 billion) and invested approximately CHF 4.0 billion (USD 2.4 billion) in R&D. Headquartered in Basel, Switzerland, Novartis employs 69,000 people and operates in over 140 countries around the world.
Headquarters: East Hanover, New Jersey
Research Facility: Summit, New Jersey
Manufacturing Facility: Suffern, New York
Employees: Approximately 7,000 nationwide; 3,500 in N.J.
Employees in Research & Development:
Approximately 2,200; 530 in drug discovery, 1,600 in development
Corporate Internet Address: www.pharma.us.novartis.com